A consortium of five pharmaceutical companies—AbbVie, Astex, Bristol Myers Squibb, Johnson & Johnson, and Takeda—collaborated to fine-tune OpenFold3 Preview 2, an open-source protein structure prediction AI model, using more than 20,000 proprietary protein-ligand structures from their internal drug-discovery programs.